If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPharos Energy Regulatory News (PHAR)

Share Price Information for Pharos Energy (PHAR)

Share Price is delayed by 15 minutes
Get Live Data
25.00    0.30 (1.21%)
Bid:
24.90
Ask:
25.10
Spread: 0.20 (0.803%)
Market Cap: £103.53m
PHAR Live PriceLast checked at - London Stock Exchange

Intraday Pharos Energy Share Chart

Form 8 (OPD)

Today 07:00

RNS Number : 6756K
Ratio Petroleum Energy - LP
02 July 2026
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

(a) Full name of discloser:

Ratio Petroleum Energy - Limited Partnership

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Pharos Energy plc

(d) Is the discloser the offeror or the offeree?

OFFEROR

(e) Date position held:

The latest practicable date prior to the disclosure

1 July 2026

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

Class of relevant security:

 

ORD 5p

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

-

Nil

-

(2) Cash-settled derivatives:

 

Nil

-

Nil

-

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

-

Nil

-

 

TOTAL:

Nil

-

Nil

-

 

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

None

Details, including nature of the rights concerned and relevant percentages:

N/A

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

Name

Number of ordinary shares held in Offeree

% of total issued share capital of Offeree

S-Team SAS1

36,757

0.01%

1 an entity controlled by Marianne Daryabegui

 

 

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

Are any Supplemental Forms attached?

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

Date of disclosure:

2 July 2026

Contact name:

Eran Cario

Telephone number:

+97235661284

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEEAKDBBQBKDFOK
Date   Source Headline
26th Sep 202511:25 amRNSBlock Listing Application
24th Sep 20257:00 amRNS2025 Interim Results
23rd Sep 20257:00 amRNSApproval for PSC Consolidation
19th Sep 20252:08 pmRNSBlock Listing Six Monthly Return
10th Sep 20257:00 amRNSInvestor Presentation via Investor Meet Company
3rd Sep 20255:23 pmRNSHolding(s) in Company
28th Aug 20257:30 amRNSDirector/PDMR Shareholding
31st Jul 202510:36 amRNSTotal Voting Rights
29th Jul 20257:30 amRNSShare Purchases by Directors
25th Jul 20253:58 pmRNSHolding(s) in Company
23rd Jul 20253:19 pmRNSCancellation of Treasury Shares
17th Jul 20254:56 pmRNSFinal Dividend Payment Date
17th Jul 20257:00 amRNSTrading and Operations Update
30th Jun 20257:30 amRNSShare Purchases by Directors
26th Jun 20257:00 amRNSAppointment of Non-Executive Chair
10th Jun 20257:00 amRNSBlocks 125 & 126 two-year extension approval
28th May 20257:30 amRNSShare Purchases by Directors
22nd May 20253:57 pmRNSResults of Annual General Meeting
22nd May 20252:11 pmRNSDirectorate Change
15th May 20257:00 amRNS2025 AGM Trading and Operations Update
2nd May 202512:18 pmRNSHolding(s) in Company
30th Apr 20254:35 pmRNSTotal Voting Rights
29th Apr 20257:30 amRNSShare Purchases by Directors
25th Apr 20254:26 pmRNS2024 Annual Report & Accounts & 2025 Notice of AGM
23rd Apr 20257:00 amRNSManagement Change
7th Apr 20257:30 amRNSIncrease in Director Shareholding
31st Mar 20254:35 pmRNSTotal Voting Rights
28th Mar 20257:31 amRNSGrant of Share Awards to Directors
28th Mar 20257:30 amRNSShare Purchases by Directors
26th Mar 20257:00 amRNS2024 Preliminary Results
20th Mar 202510:30 amRNSBlock Listing Monthly Return
20th Mar 20257:00 amRNSInvestor Presentation via Investor Meet Company
28th Feb 20257:30 amRNSDirectors/PDMR Shareholdings
19th Feb 20257:00 amRNSMOU for the merger of the Egyptian concessions
31st Jan 202511:00 amRNSTotal Voting Rights
29th Jan 20257:00 amRNSTransaction in Own Shares & Completion of Buyback
28th Jan 20257:30 amRNSShare Purchases by Directors
27th Jan 20257:30 amRNSDirectors/PDMR Shareholdings
24th Jan 20257:30 amRNSIncrease in Director Shareholding
24th Jan 20257:00 amRNSTransaction in Own Shares
23rd Jan 20257:00 amRNSTrading and Operations Update January 2025
21st Jan 20257:00 amRNSTransaction in Own Shares
20th Jan 20257:00 amRNSTransaction in Own Shares
17th Jan 20257:00 amRNSTransaction in Own Shares
16th Jan 20257:22 amRNSTransaction in Own Shares
10th Jan 20257:00 amRNSTransaction in Own Shares
9th Jan 20257:00 amRNSTransaction in Own Shares
6th Jan 20251:24 pmRNSHolding(s) in Company
31st Dec 202412:48 pmRNSTotal Voting Rights
30th Dec 20247:30 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.